Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients

NCT02362646 is registered in ClinicalTrials.gov with Annetine Gelijns as lead sponsor.

NCT NCT02362646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02362646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
Lead sponsor
Annetine Gelijns
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2015
Completion date
August 23, 2019
Enrollment
159 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy, heart failure, ventricular dysfunction